Kaleido Biosciences (KLDO) Stock Price, News & Analysis
Company Description
Kaleido Biosciences (OTC Link: KLDO) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $4.3K.
This page collects what Stock Titan holds for KLDO, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Kaleido Biosciences (KLDO) stock last closed at $0.0001. At a market capitalization of $4.3K, KLDO is classified as a micro-cap stock with approximately 42.6M shares outstanding.
Latest News
Kaleido Biosciences has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include conferences, earnings, clinical trial. View all KLDO news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Kaleido Biosciences (KLDO) currently stands at 66.5 thousand shares, down 0.0% from the previous reporting period, representing 0.2% of the float. This relatively low short interest suggests limited bearish sentiment. With 12.4 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Kaleido Biosciences (KLDO) currently stands at 12.4 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 420.6% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
KLDO Company Profile & Sector Positioning
Kaleido Biosciences (KLDO) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing KLDO often look at related companies in the same sector, including Oncology Pharma (ONPH), BETTER THERAPEUTICS INC (BTTX), Rebus Hldgs Inc (RBSH), Cardax Inc (CDXI), and Ampio Pharma (AMPE). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate KLDO's relative position within its industry.